January 8, 2008
HIV-positive people with clinical depression who take the common antidepressants selective serotonin reuptake inhibitors are more likely to follow their treatment regimens, according to a study published in a recent online edition of the Journal of Acquired Immune Deficiency Syndromes, HealthDay News/Washington Post reports.
For the study, Michael Horberg -- director of HIV/AIDS for Kaiser Permanente in Oakland, Calif. -- and colleagues analyzed the mental health, disease progression and treatment data for nearly 3,400 HIV-positive people nationwide between 2000 and 2003. All of the participants recently had started highly active antiretroviral therapy, according to the study.
The researchers found that 42% of the participants had depression during the 12-month study period. Participants who had depression were less likely to follow their treatment regimens and had worse viral responses than participants who were not depressed, according to the study. The study found that when the participants with depression took SSRIs -- such as Celexa, Paxil, Prozac and Zoloft -- they had the same health outcomes as those who were not depressed.
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.